Risk estimation in rheumatoid arthritis: from bench to bedside (Q38182346)

30 August 2017

Risk estimation in rheumatoid arthritis: from bench to bedside (English)

1 reference

Annette van der Helm-van Mil

30 August 2017

0 references

series ordinal

1

object named as

Annette H M van der Helm-van Mil

1 reference

PubMed ID

24468938

30 August 2017

language of work or name

English

0 references

publication date

28 January 2014

1 reference

Nature Reviews Rheumatology

30 August 2017

1 reference

30 August 2017

10

1 reference

30 August 2017

3

1 reference

30 August 2017

171-180

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2013.215

30 August 2017

0 references

cites work

The prognostic value of baseline erosions in undifferentiated arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Assessing the performance of prediction models: a framework for traditional and novel measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Decision curve analysis: a novel method for evaluating prediction models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

MRI of hand and foot joints of patients with anticitrullinated peptide antibody positive arthralgia without clinical arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

A prediction rule for the development of arthritis in seropositive arthralgia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in t

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Improved treatment strategies reduce the increased mortality risk in early RA patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

A prediction rule for disease outcome in patients with Recent-onset undifferentiated arthritis: How to guide individual treatment decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: Moving toward individualized treatment decision-making

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Genetic variants in the prediction of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

How to define baseline erosiveness to predict radiologic progression in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Effectiveness of initial treatment allocation based on expert opinion for prevention of rapid radiographic progression in daily practice of an early RA cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.215

Predictors of response to TNF inhibitors in rheumatoid arthritis - do we have new tools for personalized medicine?

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24468938

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Intensive management of early rheumatoid arthritis: the TICORA and TEAR studies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24468938

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/24468938

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRRHEUM.2013.215

1 reference

PubMed ID

24468938

Dimensions Publication ID

30 August 2017

0 references

1 reference

PubMed ID

24468938